glp 1 glucagon Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1: Cell Metabolism Physiological effects of GLP‐1. GLP‐1,

Not everyone, however, has a great response to GLP-1 drugs and they can cause unpleasant side effects, like nausea, constipation and diarrhoea

In the past year or so, several autoinjector families have been extended to 5.5 mL, such as Ypsomeds YpsoMate 5.5 (based on a syringe)(11), and SHLs Maggie 5.0 (based on a cartridge).(12) The question is how much these 3 mL and 5 mL autoinjectors will eat into the market for on-body injectors

Stanton R

Tirzepatide demonstrated significant reductions in HbA1c and body weight without an increased risk of hypoglycemia

Understanding these limitations helps set realistic expectations and encourages more cautious decision-making, which ultimately reduces risk